We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy. Read more about cookies

an image
  • Register
  • Log in
  • Language

Precision Medicine:
The Swedish Industry Guide 2018

02 June 2018

Mapping the Swedish Precision Medicine Industry Landscape

The Swedish precision medicine industry landscape at first glance presents the results of the first mapping of the Swedish precision medicine industry landscape. It is a guide to 76 companies, all of which are developing innovative products and services with the potential of advancing the field. At the end of the report, there is a listing of their relevant R&D projects as well as launched products.


  • A map of technologies used by the companies
  • Description of areas of rapid technology advancement
  • Presentation of Swedish research infrastructures including Science for Life Laboratory
  • AstraZeneca's, Pfizer's and Thermo Fisher Scientific's view on precision medicine and their presence in Sweden 
  • A list of companies and their projects

“Swedish precision medicine
is a real area of growth and home
to a vibrant start-up scene.”

In this report, we have prepared a guide to 76 companies developing innovative products and services that have the potential of advancing the precision medicine sector. The companies are clustered in five major regions, where the capital region Stockholm-Uppsala is home to almost 50%. The vast majority has been spun out of academic institutions.

Precision Medicine

Want to know more about Swedish Life sciences?

Northern Europe’s most dynamic life sciences location is a hotbed of brainpower and talent that’s home to innovative companies and research organisations ranging from multinationals to small start-ups with big ideas and high ambitions.

Find out more about Life sciences - Tomorrow's world

This report is published by SwedenBIO – the Swedish Life Science Industry Organisation with support from Business Sweden, the Swedish Trade and Investment Council, and Vinnova, the Governmental Agency for Innovation and in collaboration with management consulting firm, Arthur D. Little.